U.S. sues Teva over alleged kickbacks for multiple sclerosis drug

The U.S. government sued Teva Pharmaceutical Industries Ltd on Tuesday, accusing the drugmaker of causing the submission of false claims to Medicare as a result of kickbacks it paid for its multiple sclerosis drug Copaxone.

In a complaint filed with the U.S. district court in Boston, the U.S. Department of Justice said Teva paid two third-party foundations more than $300 million to cover Medicare co-payment obligations of Copaxone patients.

The Justice Department said this generated hundreds of millions of dollars of false claims to Medicare and more revenue for Teva, whose conduct violated the federal False Claims Act.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor